Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders

NCT01817283 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: Triptolide
DRUG: cART
DRUG: placebo

Sponsor

LI Taisheng